small molecule

ICOTYDE

ICOTROKINRA HYDROCHLORIDE

Loss of exclusivityNovember 2041latest FDA-listed patent expiry

CompanyJanssen Biotech →See this company's full patent-cliff portfolio

Drug detail

Brand name	ICOTYDE
Active ingredient	ICOTROKINRA HYDROCHLORIDE
Strength	EQ 200MG BASE
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	March 2026
Marketing status	RX

Listed patents

Patent	Expires	Type
11939361	November 2041	product
11845808	January 2041	substance
12552836	July 2039	substance, product

Regulatory exclusivity

Code	Expires
NCE	March 2031

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from Janssen Biotech